Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.

Wherrett DK, Bundy B, Becker DJ, DiMeglio LA, Gitelman SE, Goland R, Gottlieb PA, Greenbaum CJ, Herold KC, Marks JB, Monzavi R, Moran A, Orban T, Palmer JP, Raskin P, Rodriguez H, Schatz D, Wilson DM, Krischer JP, Skyler JS, Type 1 Diabetes TrialNet GAD Study Group

Open source

DOI: 10.1016/s0140-6736(11)60895-7
Published: 2011 Jul 23
Container: Lancet (London, England)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-11-60895-7,
  title = {Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.},
  author = {Wherrett DK and Bundy B and Becker DJ and DiMeglio LA and Gitelman SE and Goland R and Gottlieb PA and Greenbaum CJ and Herold KC and Marks JB and Monzavi R and Moran A and Orban T and Palmer JP and Raskin P and Rodriguez H and Schatz D and Wilson DM and Krischer JP and Skyler JS and Type 1 Diabetes TrialNet GAD Study Group},
  year = {2011},
  journal = {Lancet (London, England)},
  doi = {10.1016/s0140-6736(11)60895-7},
  url = {https://doi.org/10.1016/s0140-6736(11)60895-7}
}

RIS

TY  - JOUR
TI  - Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.
AU  - Wherrett DK
AU  - Bundy B
AU  - Becker DJ
AU  - DiMeglio LA
AU  - Gitelman SE
AU  - Goland R
AU  - Gottlieb PA
AU  - Greenbaum CJ
AU  - Herold KC
AU  - Marks JB
AU  - Monzavi R
AU  - Moran A
AU  - Orban T
AU  - Palmer JP
AU  - Raskin P
AU  - Rodriguez H
AU  - Schatz D
AU  - Wilson DM
AU  - Krischer JP
AU  - Skyler JS
AU  - Type 1 Diabetes TrialNet GAD Study Group
PY  - 2011
JO  - Lancet (London, England)
DO  - 10.1016/s0140-6736(11)60895-7
UR  - https://doi.org/10.1016/s0140-6736(11)60895-7
ER  -

APA

DK, W., B, B., DJ, B., LA, D., SE, G., R, G., PA, G., CJ, G., KC, H., JB, M., R, M., A, M., T, O., JP, P., P, R., H, R., D, S., DM, W., JP, K., JS, S., & Group, T. 1. D. T. G. S. (2011). Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.. Lancet (London, England). https://doi.org/10.1016/s0140-6736(11)60895-7

Source records

pubmed · retrieved 2026-09-26T12:56:11.632Z